Keros Therapeutics, Inc. (KROS)
NASDAQ · Manufacturing · Pharmaceutical preparations
$11.63+$0.0800 (+0.69%) on the dayAs of the close; data may be delayed.
KROS price, last 12 months
Key stats
- Previous close
- $11.55
- Open
- $11.65
- Day range
- $11.29 – $11.70
- 52-week range
- $9.69 – $22.55
- Volume
- 185.9K
- Avg volume (20 days)
- 189.1K
- Market cap
- $230.4M
Performance
1W+3.9%
1M+4.6%
3M+5.8%
6M+5.0%
YTD−42.9%
1Y−26.2%
vs S&P 500, 1Y−42.9 pts
Technicals and fundamentals
About Keros Therapeutics, Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $230.4M